Veracyte Inc (NASDAQ:VCYT)

6.68
Delayed Data
As of Mar 26
 -0.28 / -4.02%
Today’s Change
6.01
Today|||52-Week Range
18.01
-30.85%
Year-to-Date

Today’s Trading

Previous close6.96
Today’s open6.91
Day’s range-- - --
Volume55,689
Average volume (3 months)59,267
Market cap$156.8M
Dividend yield--
Data as of 03/26/2015

Growth & Valuation

Earnings growth (last year)+77.89%
Earnings growth (this year)+7.04%
Earnings growth (next 5 years)--
Revenue growth (last year)+74.51%
P/E ratioNM
Price/Sales5.47
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TROVTrovagene Inc+0.12+1.80%
ERBERBA Diagnostics Inc+0.17+4.50%
GALTGalectin Therapeutic...+0.01+0.28%
TRILTrillium Therapeutic...-0.13-0.76%
Data as of 03/26/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$38.2M
Annual profit (last year)-$29.4M
Net profit margin-76.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bonnie H. Anderson
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account